Broadcast Date: Friday, September 16, 2022 from 12:00 pm to 12:00 pm (ET)


Several court cases continue to shape the biotech and pharmaceutical patent litigation. Amgen Inc. v. Sanofi-Aventis (2021) has revived the discussion on the enablement of genus claims in biotechnology inventions. Moreover, the multiple filings for abbreviated new drug applications (ANDA) also raise concerns, particularly in cases that may provoke multidistrict litigation.

These and other developments further expand the patent litigation landscape, introducing new regulations that practitioners must be aware of to avoid legal pitfalls.

Join a panel of key thought leaders and distinguished professionals organized by The Knowledge Group as they provide a comprehensive discussion of the recent litigation trends in the biotech and pharmaceutical industry. Speakers, among other things, will also offer practical tips and strategies in this ever-changing regulatory landscape.

Key topics include:

  • Recent Litigation Trends and Developments in the Biotech and Pharmaceutical Industry
  • Enablement of Genus Claims for Biotechnology Inventions
  • Multiple Filing of Abbreviated New Drug Applications (ANDA): Implications
  • Recent and Notable Court Cases
  •  What Lies Ahead


Course Level:



Advance Preparation:

Print and review course materials


Method of Presentation:

Live Webcast



General knowledge of Biotech and Pharmaceutical Patent Law


Course Code:



NY Category of CLE Credit:

Area of Professional Practice


Total Credit:

2.0 CLE


Melanie Szweras, Partner
Bereskin & Parr LLP

Melanie Szweras is a partner with Bereskin & Parr LLP. Melanie’s practice focuses on biotechnology and pharmaceutical patents including drafting and prosecution of such applications; providing validity and freedom to operate opinions as well as patent litigation matters. Melanie also advises on regulatory matters, such as labeling and advertising, for consumer goods and regulated products such as food and drugs.

Melanie is a lecturer for the second year Intellectual Property Law Course at the Lincoln Alexander School of Law at Ryerson University. She also lectures on aspects of Biotechnology and The Application Process at the University of Toronto’s Patent & Trade Secrets Law course and Osgoode Hall’s LLM Patent Law course. Melanie is a past Chair of the Intellectual Property Institute of Canada’s (IPIC) Biotechnology Patents Committee. Melanie is also Vice-Chair of the Continuing Professional Development Committee for IPIC and Community Leader of the American Intellectual Property Law Association (AIPLA) Biotechnology Committee.

Melanie received numerous awards throughout her education including the Medical Research Council Studentship and a University of Toronto Open Scholarship. She was also the Bronze Medalist for her class of 2003 at Osgoode Hall Law School.


Melanie SzwerasPartner

Bereskin & Parr LLP


Coming Soon.

Please check back again later.

Who Should Attend:

Coming Soon.

Please check back again later.


Melanie SzwerasPartner
Bereskin & Parr LLP



View Details


View Details


View Details

Join Over 150,000 Professionals Empowering Their Careers

Learn anywhere from over 1800+ live and recorded CLE CPE & Technology webcasts.